🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to examine the pre, post, and follow up effect...
Status
Completed
Location
Reno Orthopedic Center
Start Date
2020-11-30
Trial ID
NCT05058209
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
This trial is designed to expand the currently available data on the safety...
Status
Completed
Location
ECOGENE-21 Clinical Trial Center / Centre de santé et de services sociaux de Chicoutimi
Start Date
2009-02
Trial ID
NCT00891306
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-05-12
Trial ID
NCT03134638
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
The purpose of this trial is to estimate the recommended dose (RD) of \[177...
Status
Active Not Recruiting
Location
UCLA Jonsson Comp Cancer Center
Start Date
2023-11-13
Trial ID
NCT05870579
Treatments Being Tested
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested